← Open Payments lookup

PAUL KUPPINGER: Open Payments

NPI 1427456300 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$791 in 11 payments from 8 companies in 2025. Trend: 2023 $585 · 2024 $838 · 2025 $791

Food & beverage: $791
CompanyPaymentsAmount
Janssen Biotech, Inc.3$244
ABBVIE INC.1$114
Sumitomo Pharma America, Inc.1$113
Caris MPI, Inc.2$93
PFIZER INC.1$91
Bayer Healthcare Pharmaceuticals Inc.1$80
Astellas Pharma US Inc1$29
Novartis Pharmaceuticals Corporation1$26

Products named: RYBREVANT, IMBRUVICA, ORGOVYX, MI CANCER SEEK, PADCEV, Nubeqa, Cresemba, PLUVICTO.

Industry payments across AZ — which companies pay providers there.